GoldenGolden
BioAge Labs

BioAge Labs

BioAge Labs focuses on developing AI and systems biology-based solutions for slowing the aging process and treating age-related illnesses.

BioAge Labs is devoted to inhibiting the aging process and treating age-related diseases by integrating AI and systems biology. The company was founded by Kristen Fortney and Eric Morgen in 2015.

Timeline

April 14, 2021
BioAge Labs announces an exclusive agreement with Amgen to develop and commercialize an APJ agonist aimed at ameliorating muscle aging.
December 2020
BioAge Labs raises a $90,000,000 series C round from AME Cloud Ventures, Aarp Foundation, Andreessen Horowitz, Caffeinated Capital, Elad Gil, Felicis Ventures, Kaiser Foundation Hospitals, Pear, Phi-X Capital and Redpoint Ventures.
January 2019
BioAge Labs raises a $23,000,000 series B round from AME Cloud Ventures, Andreessen Horowitz, Caffeinated Capital, Felicis Ventures, Khosla Ventures, Pear and Redpoint Ventures.
July 2017
BioAge Labs raises a $10,900,000 series A round from AME Cloud Ventures, Andreessen Horowitz, Caffeinated Capital, Elad Gil, Felicis Ventures and Pear.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
BioAge Labs Series C round December 2020
90,000,000
December 2020
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Heather McKenzie
April 15, 2021
BioSpace
BGE-105 (formerly AMG 986) mimics the production of apelin, a peptide that has been found in animal studies to improve muscle regeneration and decrease mouse frailty.
Amirah Al Idrus
April 14, 2021
FierceBiotech
BioAge Labs is adding a third program to its pipeline. The new treatment, licensed from Amgen, is designed to combat muscle aging and could be useful in helping older people recover from surgery more quickly, decreasing muscle atrophy after a long hospital stay, or eventually, warding off frailty in older people.
BioSpace
April 6, 2021
BioSpace
Shanghai Stock Exchange listed biotech company HitGen Inc. ("HitGen") announced important research progress in a collaboration with BioAge Labs, Inc. ("BioAge"), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging.
Alex Keown
December 3, 2020
BioSpace
Check out some news happening today around the biopharma industry.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.